A large body of data shows the high-dose vaccine yields greater protection than standard-dose vaccines.
Resources & Literature
Recent Literature
Bardenheier BH, Baier RP, Silva JB, et al. Persistence of racial inequities in receipt of influenza vaccination among nursing home residents in the United States. Clin Infect Dis 2020 (published online Sep 29)
Benjamin-Chung J, Arnold BF, Kennedy CJ, et al. Evaluation of a city-wide school-located influenza vaccination program in Oakland, California, with respect to vaccination coverage, school absences, and laboratory-confirmed influenza: a matched cohort study. PLoS Med 2020 (published online Aug 18)
Beran J, Reynales H, Poder A, et al. Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study. Lancet Infect Dis 2021 (published online Feb 9)
Bettinger JA, De Serres G, Valiquette L, et al. 2017/18 and 2018/19 seasonal influenza vaccine safety surveillance, Canadian National Vaccine Safety (CANVAS) Network. Euro Surveill 2020 Jun 4;25(22)
Boddington NL, Pearson I, Whitaker H, et al. Effectiveness of influenza vaccination in preventing hospitalisation due to influenza in children: a systematic review and meta-analysis. Clin Infect Dis 2021 (published online Mar 28)
Boikos C, Fischer L, O'Brien D, et al. Relative effectiveness of adjuvanted trivalent inactivated influenza vaccine versus egg-derived quadrivalent inactivated influenza vaccines and high-dose trivalent influenza vaccine in preventing influenza-related medical encounters in US adults ≥65 years during the 2017-2018 and 2018-2019 influenza seasons. Clin Infect Dis 2021 (published online Feb 19)
Boikos C, Fischer L, O'Brien D, et al. Relative effectiveness of the cell-derived inactivated quadrivalent influenza vaccine versus egg-derived inactivated quadrivalent influenza vaccines in preventing influenza-related medical encounters during the 2018-2019 influenza season in the United States. Clin Infect Dis 2021 (published online Jan 5)
Boikos C, Imran M, Nguyen VH, et al. Effectiveness of the cell-derived inactivated quadrivalent influenza vaccine in individuals at high risk of influenza complications in the 2018-2019 US influenza season. Open Forum Infect Dis 2021 (published online Apr 2)
Bonnevie E, Rosenberg SD, Kummeth C, et al. Using social media influencers to increase knowledge and positive attitudes toward the flu vaccine. PLoS One 2020 (published online Oct 16)
Carnahan A, Perez JJ, Robertson AH, et al, for the EU/EEA NITAG. Systematic review of the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals aged 18 years and over. ECDC 2020 Oct
Carrera M, Lawler E, White C. Population mortality and laws encouraging influenza vaccination for hospital workers. Ann Intern Med 2021 (published online Jan 5)
Chan MS, Jamieson KJ, Albarracin D. Prospective associations of regional social media messages with attitudes and actual vaccination: a big data and survey study of the influenza vaccine in the United States. Vaccine 2020 (published online Aug 11)
Chang A, Ellingson MK, Flowers CR, et al. Influenza vaccination rates among patients with a history of cancer: analysis of the National Health Interview Survey. Open Forum Infect Dis 2021 (published online Apr 20)
Chen D, Ye Z, Pi Z, et al. Cost-effectiveness of dual influenza and pneumococcal vaccination among the elderly in Shenzhen, China. Vaccine 2021 (published online Mar 20)
Choi EJ, Park JH, Chun BC. Cost effectiveness of trivalent and quadrivalent influenza vaccines in 50- to 64-year-old adults in Korea. Vaccine 2020 (published online Jun 10)
Chung H, Buchan SA, Campigotto A, et al. Influenza vaccine effectiveness against all-cause mortality following laboratory-confirmed influenza in older adults, 2010-2011 to 2015-2016 seasons in Ontario, Canada. Clin Infect Dis 2020 (published online Dec 23)
Colrat F, Thommes E, Largeron N, et al. Economic evaluation of high-dose inactivated influenza vaccine in adults aged ≥65 years: a systematic literature review. Vaccine 2021 (published online Jan 29)
Conlon A, Ashur C, Washer L, et al. Impact of the influenza vaccine on COVID-19 infection rates and severity. 2021 Am J Infect Control (published online Feb 22)
Cowling BJ, Thompson MG, Ng TW, et al. Comparative reactogenicity of enhanced influenza vaccines in older adults. J Infect Dis 2020 (published online May 14)
Darricarrere N, Qiu Y, Kanekiyo M, et al. Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates. Sci Transl Med 2021 Mar 3;13(583)
De Figueiredo A, Simas C, Karafillakis E, et al. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. Lancet 2020 (published online Sep 10)
Drori Y, Pando R, Sefty H, et al. Influenza vaccine effectiveness against laboratory-confirmed influenza in a vaccine-mismatched influenza B-dominant season. Vaccine 2020 (published online Nov 23)
